Cargando…
CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation
Receptor tyrosine kinases, such as VEGFR, PDGFR and EGFR, play important roles in renal cancer. In this study, we investigated EGFR knockout as a therapeutic approach in renal cell carcinoma (RCC). We showed that a renal cell carcinoma cell line (RC21) has higher expression of EGFR as compared to ot...
Autores principales: | Liu, Bin, Diaz Arguello, Olivia Adaly, Chen, Deng, Chen, Siwei, Saber, Ali, Haisma, Hidde J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228069/ https://www.ncbi.nlm.nih.gov/pubmed/32413049 http://dx.doi.org/10.1371/journal.pone.0232985 |
Ejemplares similares
-
Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
por: Diaz Arguello, Olivia A., et al.
Publicado: (2021) -
Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing
por: Liu, Bin, et al.
Publicado: (2020) -
Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells
por: Chinchar, Edmund, et al.
Publicado: (2014) -
EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR
por: Novak, D. D., et al.
Publicado: (2023) -
BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
por: Zeng, Furong, et al.
Publicado: (2023)